Snickpick Investment

Investment thesis

Snickpick Investment invests in early-stage bio and healthcare technology companies. Its team consists of bio and healthcare industry experts who have founded biotech ventures and grown them into global bioenterprises. Leveraging this deep and diverse industry experience, the firm identifies companies with promising growth potential, then provides both investment and active support so these companies can realize their market value. The firm positions itself as a growth partner to venture businesses and follows a structured investment process spanning sourcing, IR, internal review, an investment review committee, post-investment and risk management, an exit review committee, and eventual exit.

Source: firm website, verified Aug 3, 2026.

Similar investors

8V

8VC

8VC is a venture capital firm investing across logistics, life sciences, healthcare, IT infrastructure, and government/defense, guided by its Smart Enterprise thesis focused on data integration and platform network effects.

$100K – $50MAM

Amadeus Capital Partners

Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.

$50K – $12.7MB

B Capital Group

B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.

$10M – $50MBE

Bessemer Venture Partners

Bessemer Venture Partners is a global venture capital firm that partners with entrepreneurs across enterprise, consumer, and healthcare sectors from early stages through growth.

$5M – $100MBR

Breyer Capital

Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.

$500K – $10M